+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SHUKRAPHAR SHUKRAPHAR

Shukra Pharmaceuticals Share Price

₹68.69 -0.22 (-0.32%)
161.18% Gain from 52W Low

19 Oct, 2026 12:09 PM (IST)

Shukra Pharmaceuticals live price: ₹68.69. It opened at ₹68 vs previous close ₹69; intraday high/low: ₹70/₹68. The 50 & 200 DMA stand at ₹54.70/₹41.60.

Shukra Pharmaceuticals Performance

  • Today's Low
  • ₹68
  • Today's High
  • ₹70
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹76
  • Open Price₹68
  • Previous Close₹69
  • Volume1,087,041
  • 50 DMA₹54.70
  • 100 DMA₹47.40
  • 200 DMA₹41.60

Shukra Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 22.75%
  • Over 3 Month + 107.33%
  • Over 6 Month + 90.49%
  • Over 1 Year + 84.5%

Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!

Invest Now

Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 89.4
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 3,040
  • P/B Ratio
  • 29.4
  • Average True Range
  • 3.5
  • EPS
  • 0.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.6
  • RSI
  • 70.7
  • MFI
  • 78.06

Latest Stock News Updates

Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Change of Company Name

Change of Name by MCA

Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Reg 74(5)

Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants

Allotment of Shares pursuant to conversion of Warrants

Shukra Pharmaceuticals Financials

Shukra Pharmaceuticals Technicals

EMA & SMA

Current Price
₹68.69
-0.22 (-0.32%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹63.30
  • 50 Day
  • ₹54.70
  • 100 Day
  • ₹47.40
  • 200 Day
  • ₹41.60

Resistance and Support

68.73 Pivot Speed
  • R3 76.50
  • R2 74.20
  • R1 71.50
  • S1 66.60
  • S2 64.20
  • S3 61.60

Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-22 A.G.M.
2026-08-12 Quarterly Results
2026-06-10 Others Inter-alia, to consider 1. Ratification of Approval for member's resolution passed in the EGM. 2. To approve draft of notice of postal ballot. 3. Other business matters.
2026-05-07 Audited Results & Final Dividend
2026-03-16 Others Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters.
Date Purpose Remarks
2026-09-21 FINAL Rs.0.01 per share(1%)Final Dividend
2025-09-18 FINAL Rs.0.01 per share(1%)Final Dividend
View Shukra Pharmaceuticals Dividend History Arrow
Date Purpose Remarks
2025-03-21 Split Stock split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2024-04-20 Bonus Bonus issue in the ratio of 3:1 of Rs. 10/-.

Shukra Pharmaceuticals Shareholding Pattern

50.96%
48.93%
0.11%

About Shukra Pharmaceuticals

Shukra Pharmaceuticals is engaged in the manufacturing, marketing, and export of pharmaceutical formulations. The Company caters to both domestic and international markets, with a growing presence in countries such as Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen. View More
  • NSE Symbol
  • SHUKRAPHAR
  • BSE Symbol
  • 524632
  • ISIN
  • INE551C01044

Similar Stocks to Shukra Pharmaceuticals

Shukra Pharmaceuticals FAQs

Shukra Pharmaceuticals share price is ₹68 As on 19 October, 2026 | 11:57

The Market Cap of Shukra Pharmaceuticals is ₹3039.7 Cr As on 19 October, 2026 | 11:57

The P/E ratio of Shukra Pharmaceuticals is 89.4 As on 19 October, 2026 | 11:57

The PB ratio of Shukra Pharmaceuticals is 29.4 As on 19 October, 2026 | 11:57

The 52 week High & Low of Shukra Pharmaceuticals is ₹75.5/₹26.3 respectively As on 19 October, 2026 | 11:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23